Variational Autoencoder for Anti-Cancer Drug Response Prediction
share
Cancer is a primary cause of human death, but discovering drugs and tailoring cancer therapies are expensive and time-consuming. We seek to facilitate the discovery of new drugs and treatment strategies for cancer using variational autoencoders (VAEs) and multi-layer perceptrons (MLPs) to predict anti-cancer drug responses. Our model takes as input gene expression data of cancer cell lines and anti-cancer drug molecular data and encodes these data with our GeneVae model, which is an ordinary VAE model, and a rectified junction tree variational autoencoder (JTVae) model, respectively. A multi-layer perceptron processes these encoded features to produce a final prediction. Our tests show our system attains a high average coefficient of determination (R^2 = 0.83) in predicting drug responses for breast cancer cell lines and an average R^2 > 0.84 for pan-cancer cell lines. Additionally, we show that our model can generates effective drug compounds not previously used for specific cancer cell lines.
READ FULL TEXT
